E-selectin plays an important role in the interaction of cancer cells with the bone marrow (BM) microvasculature; hence, impeding these interactions not only blocks cell tethering, rolling and extravasating but also mobilizes cancer cells to circulation where they are more susceptible to chemotherapy [1]. Here, SELE is linked to cancer.